Published in Ther Drug Monit on January 01, 1980
Verapamil-induced changes in central conduction in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry (1985) 0.81
Peripheral beta-adrenergic receptors concerned with tremor. Clin Sci (1967) 2.97
Pharmacy College Admission Test (PCAT) as a predictor of academic success. Am J Pharm Educ (1976) 2.47
Pharmacy College Admission Test (PCAT) as a predicator of academic success. II: A progress report. Am J Pharm Educ (1977) 2.16
Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects. J Clin Pharmacol (1983) 1.76
The effect of chronic adrenergic receptor blockade on plasma renin activity in man. J Clin Endocrinol Metab (1972) 1.75
Effect of beta-adrenergic blockade on finger tremor and Achilles reflex time in anxious and thyrotoxic patients. Acta Endocrinol (Copenh) (1968) 1.48
Suppression of essential tremor by propranolol: correlation of effect with drug plasma levels and intensity of beta-adrenergic blockade. Ann Neurol (1977) 1.36
Fulminant beriberi heart disease with lactic acidosis: presentation of a case with evaluation of left ventricular function and review of pathophysiologic mechanisms. Circulation (1978) 1.30
Propranolol therapy during pregnancy, labor, and delivery: evidence for transplacental drug transfer and impaired neonatal drug disposition. J Pediatr (1977) 1.28
The pharmacology of verapamil. IV. Kinetic and dynamic effects after single intravenous and oral doses. Clin Pharmacol Ther (1982) 1.21
Levels of non-ortho-substituted (coplanar), mono- and di-ortho-substituted polychlorinated biphenyls, dibenzo-p-dioxins, and dibenzofurans in human serum and adipose tissue. Environ Health Perspect (1994) 1.06
Effects of nifedipine on esophageal motor function in humans: correlation with plasma nifedipine concentration. Gastroenterology (1984) 1.05
Clinical pharmacokinetics of verapamil. Clin Pharmacokinet (1984) 1.05
Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease. Am J Cardiol (1981) 1.04
Failure of single-session dietary counseling to reduce salt intake in hypertensive patients. South Med J (1977) 0.99
Reversal of the cardiovascular effects of verapamil by calcium and sodium: differences between electrophysiologic and hemodynamic responses. Circulation (1979) 0.99
Effect of adrenergic receptor blockade on the responses to isometric handgrip: studies in normal and hypertensive subjects. J Cardiovasc Pharmacol (1980) 0.96
Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2. Diabetes Technol Ther (2002) 0.95
The pharmacology of verapamil. V. Tissue distribution of verapamil and norverapamil in rat and dog. Pharmacology (1983) 0.95
Hemodynamic consequences of combined beta-adrenergic and slow calcium channel blockade in man. Circulation (1982) 0.94
Kinetics and dynamics of nifedipine after oral and sublingual doses. Am J Med (1986) 0.92
Measurement of nifedipine in plasma by gas--liquid chromatography and electron-capture detection. Clin Chem (1983) 0.92
Chemiluminescent detection of artemisinin. Novel endoperoxide analysis using luminol without hydrogen peroxide. J Chromatogr A (1995) 0.92
Clinical pharmacology of slow channel blocking agents. Prog Cardiovasc Dis (1982) 0.89
Use of a programmable hand-held calculator for clinical pharmacokinetics. Am J Hosp Pharm (1977) 0.89
Intravenous verapamil for termination of re-entrant supraventricular tachycardias: intracardiac studies correlated with plasma verapamil concentrations. Ann Intern Med (1980) 0.89
Clinical pharmacokinetics of calcium channel antagonists. J Cardiovasc Pharmacol (1982) 0.89
Long-term malaria chemoprophylaxis with mefloquine in Dutch marines in Cambodia. J Infect Dis (1996) 0.89
Disposition of sulfonamides in food-producing animals: concentrations of sulfamethazine and its metabolites in plasma, urine, and tissues of lambs following intravenous administration. Am J Vet Res (1977) 0.89
Electrophysiologic and hemodynamic effects of verapamin. Correlation with plasma drug concentrations. Circulation (1978) 0.89
Nature of nicotine binding to rat brain P2 fraction. Pharmacol Biochem Behav (1984) 0.88
Malignant hypertension: effect of therapy on renin and aldosterone. Circ Res (1971) 0.88
Monitoring for mefloquine-resistant Plasmodium falciparum in Africa: implications for travelers' health. Am J Trop Med Hyg (1998) 0.88
MULTI-FORTE, a microcomputer program for modelling and simulation of pharmacokinetic data. Comput Methods Programs Biomed (1986) 0.88
Effect of nifedipine on gastric emptying in normal subjects. Dig Dis Sci (1985) 0.87
Fluorometric assay of verapamil in biological fluids and tissues. J Pharm Sci (1976) 0.87
Plasma renin activity in chronic plumbism. Effect of treatment. Arch Intern Med (1971) 0.87
Determination of nitrazepam and temazepam in plasma by high-performance liquid chromatography. Ther Drug Monit (1983) 0.86
Efficacy of verapamil in exercise-induced ventricular tachycardia. Am J Cardiol (1985) 0.86
Improving the effect of FDA-mandated drug safety alerts with Internet-based continuing medical education. Curr Drug Saf (2013) 0.85
The effects of age and sex on the disposition of acetylsalicylic acid and its metabolites. Br J Clin Pharmacol (1985) 0.85
Pharmacokinetics of cefotaxime in the dog. Vet Rec (1986) 0.85
Intravenous propranolol administration: a method for rapidly achieving and sustaining desired plasma levels. Clin Pharmacol Ther (1976) 0.84
Tricuspid regurgitation following inferior myocardial infarction. Arch Intern Med (1976) 0.83
Verapamil plasma levels and ventricular rate response in patients with atrial fibrillation and flutter. Clin Pharmacol Ther (1979) 0.83
A Wandering Enteropneust from the Abyssal Pacific, and the Distribution of "Spiral" Tracks on the Sea Floor. Science (1965) 0.83
Pharmacokinetics of calcium-entry blockers. Am J Cardiol (1985) 0.83
The role of the kidney in the elimination of cephapirin in man. J Pharmacokinet Biopharm (1975) 0.83
Macroglossia--a positional complication. Anesthesiology (1974) 0.82
Peripheral beta-receptor responsiveness in patients with essential hypertension. Arch Intern Med (1979) 0.82
Effects of hemodynamic changes on the elimination kinetics of verapamil and nifedipine. J Pharmacol Exp Ther (1984) 0.82
Verapamil-induced changes in central conduction in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry (1985) 0.81
Field detection of sulfonamides in urine: the development of a new and sensitive test. Am J Trop Med Hyg (1996) 0.81
Studies of experimental cervical spinal cord transection. Part II: Plasma norepinephrine levels after acute cervical spinal cord transection. J Neurosurg (1979) 0.81
Effects of hypothermia on propranolol kinetics. Clin Pharmacol Ther (1979) 0.81
Disposition of sulfadimethoxine in swine: inclusion of protein binding factors in a pharmacokinetic model. J Pharmacokinet Biopharm (1982) 0.81
Effect of hypothermia on drug metabolism. In vitro studies with propranolol and verapamil. Pharmacology (1980) 0.81
Disposition of aerosolized liposomal amphotericin B. J Pharm Sci (1997) 0.81
A correlation of the sequestration rate of Plasmodium coatneyi-infected erythrocytes in cerebral and subcutaneous tissues of a rhesus monkey. Am J Trop Med Hyg (1996) 0.80
New high-performance liquid chromatographic method for amphotericin B analysis using an internal standard. J Chromatogr B Biomed Appl (1996) 0.80
Disposition of cefotaxime and its metabolite, desacetylcefotaxime, in rat: application of a pharmacokinetic-protein binding model. Xenobiotica (1989) 0.80
Pharmacokinetics of cefotaxime in sheep. Am J Vet Res (1983) 0.80
Pharmacokinetics of cefaronide, ceftriaxone and cefoperazone in sheep. J Vet Pharmacol Ther (1985) 0.80
Determination of gallium concentration in "blood-free" tissues using a radiolabeled blood marker. J Pharm Sci (1985) 0.80
Age-related changes in drug handling in man. Am J Cardiol (1986) 0.79
Correlation of plasma levels of nifedipine and cardiovascular effects after sublingual dosing in normal subjects. J Clin Pharmacol (1985) 0.79
The pharmacology of verapamil. III. Pharmacokinetics in normal subjects after intravenous drug administration. J Cardiovasc Pharmacol (1981) 0.79
Malignant hypertension due to renal artery stenosis. Greater renin release from the nonstenotic kidney. JAMA (1972) 0.79
Disposition of sulfonamides in food-producing animals IV: Pharmacokinetics of sulfamethazine in cattle following administration of an intravenous dose and three oral dosage forms. J Pharm Sci (1977) 0.78
Studies of experimental cervical spinal cord transection. Part IV: Effects of cervical spinal cord transection on myocardial blood flow in anesthetized dogs. J Neurosurg (1980) 0.78
The pharmacology of verapamil. I. Elimination kinetics in dogs and correlation of plasma levels with effect on the eletrocardiogram. J Pharmacol Exp Ther (1977) 0.78
Malaria in Brazilian military personnel deployed to Angola. J Travel Med (2001) 0.78
Bioavailability of intranasal scopolamine in normal subjects. J Pharm Sci (1996) 0.78
Metabolism and metabolite pharmacokinetics of BRB-I-28, a class Ib antiarrhythmic agent. Eur J Drug Metab Pharmacokinet (1996) 0.78
The pharmacokinetics of pentazocine and tripelennamine. Clin Pharmacol Ther (1986) 0.78
Fever, tachycardia, and hypertension with acute catatonic schizophrenia. Arch Intern Med (1978) 0.78
Studies of experimental cervical spinal cord transection. Part III: Effects of acute cervical spinal cord transection on cerebral blood flow. J Neurosurg (1979) 0.77
Subcutaneously implanted tissue chambers--a pharmacokinetic study. J Vet Pharmacol Ther (1989) 0.77
Gastrointestinal absorption of phenytoin from an oil-in-water microemulsion. Arch Pharm Res (1997) 0.77
The effects of verapamil and lidocaine on the automatic depolarizations in guinea-pig ventricular myocardium. J Pharmacol Exp Ther (1978) 0.77
Effect of probenecid on the pharmacokinetics of cefotaxime in sheep. J Vet Pharmacol Ther (1985) 0.77
Effect of intravenous furosemide on the renal excretion of digoxin. J Clin Pharmacol (1976) 0.77
Disposition of ceftriaxone in rat: application of a pharmacokinetic-protein binding model and comparison with cefotaxime. Xenobiotica (1989) 0.77
Clinical and medicoeconomic impact of the cyclosporine-diltiazem interaction in renal transplant recipients. Pharmacotherapy (1994) 0.77
Absence of slow channel-dependent conduction within the His-Purkinje (bundle branch) reentrant circuit: a clinical and experimental study of the effects of verapamil. Am J Cardiol (1982) 0.77
Physiological model for distribution of sulfathiazole in swine. J Pharm Sci (1984) 0.77
High-performance liquid chromatographic assay of cefotaxime, desacetylcefotaxime and ceftriaxone in rat plasma. J Chromatogr (1988) 0.76
Pharmacokinetics of canrenone and metabolites after base hydrolysis following single and multiple dose oral administration of spironolactone. Eur J Clin Pharmacol (1984) 0.76
Cardiovascular and pharmacokinetic consequences of combined administration of verapamil and propranolol in dogs. Am J Cardiol (1985) 0.76
Effects of intravenous and oral verapamil upon pressor and adrenal steroidogenic responses in normal man. J Clin Endocrinol Metab (1983) 0.76
Packed-column supercritical fluid chromatography of artemisinin (qinghaosu) with electron-capture detection. J Chromatogr B Biomed Appl (1995) 0.76
Effect of verapamil on retrograde conduction in atrioventricular nodal reentrant tachycardia. Am J Cardiol (1984) 0.76
Aspects of the clinical pharmacology of verapamil, a calcium-entry antagonist. Biopharm Drug Dispos (1983) 0.75
Effect of beta-adrenergic blockade on hypothermia-induced hypokalemia. Surg Forum (1977) 0.75
Extension of the serum digoxin concentration--response relationship to patient management. J Clin Pharmacol (1989) 0.75